Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3321924rdf:typepubmed:Citationlld:pubmed
pubmed-article:3321924lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3321924lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:3321924lifeskim:mentionsumls-concept:C0011854lld:lifeskim
pubmed-article:3321924lifeskim:mentionsumls-concept:C0152020lld:lifeskim
pubmed-article:3321924lifeskim:mentionsumls-concept:C0072916lld:lifeskim
pubmed-article:3321924lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3321924lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:3321924pubmed:issue4lld:pubmed
pubmed-article:3321924pubmed:dateCreated1988-2-2lld:pubmed
pubmed-article:3321924pubmed:abstractTextFourteen insulin-dependent diabetics with symptoms and signs of delayed gastric emptying were treated with a new prokinetic agent, cisapride. In a placebo-controlled cross-over trial no significant differences from placebo was found regarding overall symptomatic effects and effects on gastric emptying of a mixed solid/liquid isotope marked test meal. Solid emptying was most markedly delayed in diabetics compared with healthy controls, but the emptying rate was not correlated to the severity of symptoms as observed for liquid emptying. During active treatment with cisapride the amelioration of symptoms was correlated to increased emptying rates assessed by combined measure of liquid/solid gastric emptying.lld:pubmed
pubmed-article:3321924pubmed:languageenglld:pubmed
pubmed-article:3321924pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3321924pubmed:citationSubsetIMlld:pubmed
pubmed-article:3321924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3321924pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3321924pubmed:statusMEDLINElld:pubmed
pubmed-article:3321924pubmed:issn0001-6101lld:pubmed
pubmed-article:3321924pubmed:authorpubmed-author:LauritsenKKlld:pubmed
pubmed-article:3321924pubmed:authorpubmed-author:Oster-Jørgens...lld:pubmed
pubmed-article:3321924pubmed:authorpubmed-author:LarsenM LMLlld:pubmed
pubmed-article:3321924pubmed:authorpubmed-author:EshøjOOlld:pubmed
pubmed-article:3321924pubmed:authorpubmed-author:HavelundTTlld:pubmed
pubmed-article:3321924pubmed:issnTypePrintlld:pubmed
pubmed-article:3321924pubmed:volume222lld:pubmed
pubmed-article:3321924pubmed:ownerNLMlld:pubmed
pubmed-article:3321924pubmed:authorsCompleteYlld:pubmed
pubmed-article:3321924pubmed:pagination339-43lld:pubmed
pubmed-article:3321924pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3321924pubmed:meshHeadingpubmed-meshheading:3321924-...lld:pubmed
pubmed-article:3321924pubmed:meshHeadingpubmed-meshheading:3321924-...lld:pubmed
pubmed-article:3321924pubmed:meshHeadingpubmed-meshheading:3321924-...lld:pubmed
pubmed-article:3321924pubmed:meshHeadingpubmed-meshheading:3321924-...lld:pubmed
pubmed-article:3321924pubmed:meshHeadingpubmed-meshheading:3321924-...lld:pubmed
pubmed-article:3321924pubmed:meshHeadingpubmed-meshheading:3321924-...lld:pubmed
pubmed-article:3321924pubmed:meshHeadingpubmed-meshheading:3321924-...lld:pubmed
pubmed-article:3321924pubmed:year1987lld:pubmed
pubmed-article:3321924pubmed:articleTitleEffects of cisapride on gastroparesis in patients with insulin-dependent diabetes mellitus. A double-blind controlled trial.lld:pubmed
pubmed-article:3321924pubmed:affiliationDepartment of Medical Gastroenterology, Odense University Hospital, Denmark.lld:pubmed
pubmed-article:3321924pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3321924pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3321924pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3321924lld:pubmed